✦ LIBER ✦

Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma

✍ Scribed by Kazunari Yamada; Kenta Izaki; Koji Sugimoto; Hiroshi Mayahara; Yoshitaka Morita; Eisaku Yoden; Shinichi Matsumoto; Toshinori Soejima; Kazuro Sugimura

Book ID: 108435187
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 86 KB
Volume: 57
Category: Article
ISSN: 0360-3016
DOI: 10.1016/s0360-3016(03)00434-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transcatheter arterial chemoembolization

Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis

✍ J. H. KIM; H.-K. YOON; S. Y. KIM; K. M. KIM; G.-Y. KO; D. I. GWON; K.-B. SUNG 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Intra-arterial 5-fluorouracil/interferon

Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis

✍ Yoshio Katamura; Hiroshi Aikata; Shintaro Takaki; Takahiro Azakami; Tomokazu Kaw 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 297 KB

The safety and efficacy of transcatheter

The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction : A prospective controlled study

✍ Hyo-Suk Lee; Joo Sung Kim; Il Ju Choi; Jin Wook Chung; Jae Hyung Park; Chung Yon 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 3 views

## Background: Transcatheter arterial chemoembolization (tace) has been contra-indicated for the treatment of patients with hepatocellular carcinoma (hcc) and main portal vein (mpv) obstruction because of the potential risk of hepatic insufficiency resulting from ischemia after tace. the current co

Midterm outcomes in patients with interm

Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma : A randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization

✍ Manabu Morimoto; Kazushi Numata; Masaaki Kondou; Akito Nozaki; Satoshi Morita; K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views